The purpose is to monitor far field sensing artifacts of CRM devices in the presence of the IMED-4
The implanted CRM device will have shock therapy and rate sensor temporarily deactivated or placed in magnet mode during the time the IMED-4 is activated. The IMED-4 will be activated for a time not to exceed 15 minutes. During the time the IMED-4 is active, the CRM device programmer will print the voltage sensing of the implanted lead in real-time. The printout will be examined for the presence of far-field sensing artifacts.
Study Type
OBSERVATIONAL
Enrollment
24
North Coast Cardiology
Encinitas, California, United States
Desert Heart
Palm Springs, California, United States
IMED-4 recordings
The primary endpoint is a collection of CRM device programmer printouts containing real-time lead sensing data from up to 40 unique subjects.
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.